NEW YORK (GenomeWeb) – Singapore-based Clearbridge Biomedics and Germany-based Leica Biosystems (LBS) have partnered to comarket each other's products in order support research on circulating tumor cells.

The companies will comarket Clearbridge's ClearCell CTC enrichment system and LBS' Bond Rx staining platform, creating an integrated and automated workflow for CTC enrichment and immunostaining.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

The New York City medical examiner is overseeing an effort to identify missing persons using DNA, according to the Associated Press.

Nobel laureate Günter Blobel has died at 81, the New York Times reports.

In PNAS this week: mouse model of genetically induced emphysema, gene expression signatures of circulating melanoma cells, and more.

Technology Review reports that 2017 was the year of consumer genetic testing and that it could spur new analysis companies.